CrossAssetDataThe Company File
···
CVSA

Covista Inc.

Covista Inc. is classed by the SEC under Services-Educational Services (industry code 8200), based in Chicago, IL. In its latest annual figures on file, for the fiscal year ended 2025-06-30, it reported revenue of $1.8 billion and a profit of $237 million (its filed statements).

Usage business Services-Educational Services Chicago, IL filings since 1995 9 of 9 filed
Ask the desk about CVSA → Compare CVSA with LRN → Price chart on TradingView ↗ Full EDGAR file ↗ Watch CVSA →

Sector peers: LRNLAURSTRATAL

6.7/10headline grade
vs its business-model standard
6.9/10past 6.7/10present 6.5/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8200, Services-Educational Services); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 6.7 out of ten, 9 of 9 metrics filed: past 6.9 out of ten, present 6.7 out of ten, future 6.5 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 7.3 out of ten. No warning events in its filings since 2017. 73rd percentile among 42 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 5.7 out of ten. +5.5% a year over 10 filed years; profitable in 9 of 10. 57th percentile among 39 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 8.6 out of ten. Share count shrank 7.8% a year. 65% of cash flow returned. Insiders: 17 sales, 6 purchases. 86th percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Financial health (present): 7.0 out of ten. ROE 17%: 17¢ of profit per shareholder dollar. Leverage 52%: owes 52¢ per asset dollar. 70th percentile among 41 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 7.3 out of ten. top 27% of 40 in its family; net margin 12.9%. 73rd percentile among 40 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 4.9 out of ten. bottom 49% of 13 in its family for leadership; chief executive since 2021. 49th percentile among 13 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 5.6 out of ten. top 44% of 40 in its family for room to expand. 56th percentile among 40 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 7.2 out of ten. top 28% of 39 in its family for growth drivers. 72nd percentile among 39 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 6.1 out of ten. top 39% of 36 in its family for expectations against reality. 61st percentile among 36 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-05-07 for the period ended 2026-03-31 (on EDGAR). Newest results release: Form 8-K filed 2026-08-06 (on EDGAR). Newest filing: Form 144, 2026-10-09. Filings on record since 1995. Read from EDGAR 2026-10-12.

Where the revenue comes from

Lines of business in fiscal 2026: Walden University 41%, Chamberlain University 38%, Medical and Veterinary 20%. By geography: Domestic Operations 80%, Barbados, St. Kitts, St. Maarten, and the U.K 20%. As tagged in its annual report (Form 10-K, filed 2026-08-06).

Who runs it

Beard,, Stephen W. (Chairman & CEO); Wardell, Lisa W (Chairman, President and CEO); Manning, Amelia (President, Chamberlain Univ.); Cox, Karen Sue (President, Chamberlain Univ.); Liles, Scott (President, Medical and Vet); Trent, Evan (President, Adtalem Elevate); Phelan, Robert J. (Chief Financial Officer); Gangadharan, Manjunath (VP, Chief Accounting Officer); Herrera, Maurice (SVP - Chief Marketing Officer); Noel, Megan (Chief Corp. Affairs Officer); and 13 more. 23 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-09.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.